WAVE Life Sciences To Present At The Deutsche Bank 41st Annual Health Care Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--WAVE Life Sciences Ltd. (NASDAQ: WVE), a genetic medicines company focused on developing stereopure nucleic acid therapies for patients with rare diseases, today announced that Paul Bolno, M.D., MBA, President and Chief Executive Officer, will present at the Deutsche Bank 41st Annual Health Care Conference at 3:30 PM EDT on Wednesday, May 4, 2016 in Boston, Mass.

Back to news